-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$0.9531.94% Upside
Cyclo Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Cyclo Therapeutics, Inc.?
Cyclo Therapeutics, Inc. has been rated by research analysts at Ascendiant in the past 90 days.